Boehringer Ingelheim and Tsinghua University (Beijing) have jointly announced a scientific partnership aimed at developing new immunotherapies for the treatment of infectious diseases.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,